- Home
- GROW vs ANVS Comparison
GROW vs ANVS Comparison
Compare GROW & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- ANVS
- Stock Information
- Founded
- GROW 1968
- ANVS 2008
- Country
- GROW United States
- ANVS United States
- Employees
- GROW N/A
- ANVS N/A
- Industry
- GROW Investment Managers
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- ANVS Health Care
- Exchange
- GROW Nasdaq
- ANVS Nasdaq
- Market Cap
- GROW 27.4M
- ANVS 24.2M
- IPO Year
- GROW N/A
- ANVS 2020
- Fundamental
- Price
- GROW $2.16
- ANVS $1.70
- Analyst Decision
- GROW
- ANVS Strong Buy
- Analyst Count
- GROW 0
- ANVS 4
- Target Price
- GROW N/A
- ANVS $40.67
- AVG Volume (30 Days)
- GROW 18.6K
- ANVS 470.9K
- Earning Date
- GROW 05-08-2025
- ANVS 05-20-2025
- Dividend Yield
- GROW 4.19%
- ANVS N/A
- EPS Growth
- GROW N/A
- ANVS N/A
- EPS
- GROW 0.01
- ANVS N/A
- Revenue
- GROW $8,932,000.00
- ANVS N/A
- Revenue This Year
- GROW N/A
- ANVS N/A
- Revenue Next Year
- GROW N/A
- ANVS N/A
- P/E Ratio
- GROW $203.47
- ANVS N/A
- Revenue Growth
- GROW N/A
- ANVS N/A
- 52 Week Low
- GROW $2.02
- ANVS $1.11
- 52 Week High
- GROW $2.73
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- GROW 49.46
- ANVS 57.36
- Support Level
- GROW $2.09
- ANVS $1.48
- Resistance Level
- GROW $2.23
- ANVS $1.74
- Average True Range (ATR)
- GROW 0.05
- ANVS 0.16
- MACD
- GROW 0.01
- ANVS 0.03
- Stochastic Oscillator
- GROW 50.00
- ANVS 87.18
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.